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ABSTRACT The increase of fluorescence emission of lucensomycin occurring
upon interaction with cholesterol, either as colloidal suspension or included in
phospholipid micelles or in erythrocyte membranes, was described. Colloidal
cholesterol differed from that contained in membranes by the kinetic behavior of
its interaction with lucensomycin, the reaction being very slow in the former case,
very fast in the latter one. Variations of optical density also occurred, though
neither the kinetics nor the titration curves were superimposable on those ob-
tained fluorometrically. The stoichiometry was, however, the same.
INTRODUCTION
In a previous communication (1) we had reported the enhancement of the fluo-
rescence of the macrolide polyenic antibiotic lucensomycin (trade name: etruscomy-
cinm) upon binding to erythrocyte membranes. The fluorescence quantum yield,
which in aqueous solution was as low as 0.3 X 10-3, increased, upon addition of
membranes, to values around 0.25.
We report here experiments in model systems and in beef erythrocyte membranes
indicating that cholesterol is the binding site, the combination of which with the
polyene gives rise to the increase of fluorescence. Although the presence or absence
of phospholipids around the cholesterol moieties influences largely the kinetics of
fluorescence increase and, as shall be shown in the following paper, also the nature
of the fluorescent complex, a preliminary evaluation of some binding parameters
can be done, and the mobility of the lucensomycin-cholesterol complex evaluated.
MATERIALS AND METHODS
Lucensomycin and N-acetyl-lucensomycin were kind gifts of Prof. F. Arcamone and Prof. M.
Ghione of Farmitalia, Milano, Italy. Filipin III, 96% pure, was supplied by Dr. George B.
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Whitfield of the Upjohn Co., Kalamazoo, Mich. The polyenes were kept as dry powders
under nitrogen at 4°C until use, then dissolved at 5-15 mg/ml in dimethylsulfoxide, and this
stock solution diluted in the appropriate solvent. Most experiments were performed in iso-
tonic NaCl + isotonic phosphate buffer pH 6.8 (9:1, v/v); when different pHs were de-
sired, isotonic buffers containing 0.03 M glycine, KH2PO4, and/or citric acid were used.
Proteins were determined according to Gornall et al. (2) and verified by use of a Coleman
nitrogen analyzer (Coleman Instruments Div., Perkin Elmer Corp., Maywood, Ill.) and
by their absorbance at 280 nm after addition of 3% (w/v, final concentration) sodium dode-
cylsulfate. Cholesterol was determined with the 15949 TCAA colorimetric test of Boehringer,
Mannheim, Germany. Phospholipids were analyzed by thin-layer chromatography on silica
gel, using chloroform-methanol-acetic acid-water (25:15:4:2, v/v) as the developing solvent
(3), followed by a spray with potassium dichromate in sulfuric acid and charring in an oven
at 100°C.
Crude egg lecithin, containing about 60% phosphatidylcholine and smaller amounts of
phosphatidylethanolamine, phosphatidylserine, and lysophosphatidylcholine, was ob-
tained from E. Merck, Darmstadt, Germany; purified phosphatidylcholine was obtained
from Sigma Chemical Co. (St. Louis, Mo.). Lipid micelles were prepared by suspending the
crude lecithin or the purified phosphorylcholine in the isotonic NaCl-phosphate solution;
the suspension was then clarified by 15 min sonication with an MSE 100 W sonifier (Meas-
uring and Scientific Equipment Ltd., London, England). If desired, cholesterol, dissolved
in diethyl ether, was added during sonication; the sonication vessel was then brought to 37'C
to allow evaporation of ether. A 10:1 proportion (w/w) between phospholipids and choles-
terol was generally maintained.
Colloidal suspensions of cholesterol in twice-distilled water were prepared according to
Stadtman (4), by slow addition on the boiling water of 0.12 vol of acetone in which 500
mg of cholesterol had been dissolved. After complete evaporation of acetone and subse-
quent cooling, the milky filtrate contained about 0.2 mg cholesterol/ml.
Erythrocyte ghosts were prepared according to Dodge et al. (5), with minor modifications,
and resuspended by sonication in the isotonic NaCl-phosphate solution. Most experiments
reported in the present paper were performed using the same membrane preparation, con-
taining 2.64 mg protein/ml and 0.55 mg cholesterol/ml. Other preparations, however, be-
haved in an identical manner.
Mitochondria were prepared from rat liver, according to Schneider (6) and fragmented
by repeated freezing and thawing in hypotonic (0.03 M) phosphate buffer pH 7.6, followed
by 45 min centrifugation at 145,000 g.
The fluorescence spectra were recorded in an Aminco Bowman spectrophotofluorometer
(American Instrument Co., Inc., Travenol Laboratories Inc., Silver Spring, Md.), using I
cm cuvettes, excitation slit of 0.1 mm, and emission slit between 0.1 and 0.5 mm. The fluores-
cence unit was arbitrarily defined as corresponding to 0.4mV at the recorder output. In some
cases, quantum yield was determined from the area of the emission curve by comparison with
that of a quinine disulfate standard (7).
The degree of polarization p was evaluated according to the well-known formula
p = (Iu - IA)/(II + Is.),
correcting for measurement artifacts by repeated measurements and according to Burns (8).
Absorption spectra were obtained on a Beckman DK2 spectrophotometer (Beckman In-
struments, Inc., Fullerton, Calif.), and circular dichroism (CD) spectra on a Cary 60 spec-
tropolarimeter (Cary Instruments, Monrovia, Calif.) equipped with a model 6002 CD
attachment. In all cases the background was subtracted.
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AU measurements were effected after attainment of equilibrium, as checked by repeated
measurements or by previous investigation of the kinetics of the reaction; generally, a delay
of 3-4 h or even more between preparation and reading of the samples was observed.
RESULTS
Fluorescence Increase upon Binding to Cholesterol Molecules
As previously reported (1), in the absence of membranes the fluorescence of lucenso-
mycin in aqueous solution at neutral pH was extremely low, and increased very
sensibly upon addition of membranes. Excitation spectra showed, like absorption
ones, maxima at 291, 305, and 320 nm. The emission spectrum had a peak centered
at 410 nm, which, under the experimental conditions used, was structureless. Typical
titration curves can be obtained.
Preliminary kinetics experiments indicated that, in the observable range (lucenso-
mycin > 0.3 ,uM, membrane cholesterol > 1 AM), the fluorescence increase oc-
curred at a rate too high to be followed with conventional mixing techniques,
being practically complete within 6-10 s. Fluorescence of lucensomycin-membrane
complex showed (Fig. 1), upon variation of pH, a wide maximum in the neutral
range, decreasing at pH < 3 (pK - 2) and at pH > 8 (pK 9.3). These results
are consistent with the amphoteric nature of lucensomycin, which has (9) a car-
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FIGURE 1 pH dependence of the fluorescence intensity of membrane-lucensomycin com-
plex. Measurements were performed with a 1.6 pM aqueous solution of lucensomycin
(0-O) or N-acetyl-lucensomycin (A-A) in the presence of an amount of erythrocyte
membranes corresponding to 32 nmol cholesterol/ml.
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FIGURE, 2jFluorometric titration of 4 pM lucensomycin with a 1 mg/ml suspension of egg
r lecithin, without (0) or with 25 ,g/mi (A) or 100 pg/mI (-) cholesterol.
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FiouRE 3 Fluorometric titration of cholesterol (A) or deoxycholate (B) with increasing
amounts of lucensomycin. Cholesterol concentrations: 0.52 pM (0 *); 1.3 pM(0-0); 5.2 pM (A-A); 13 pM (0 0). Na deoxycholate ( U- : 6 mM.
All data are normalized to the same steroid concentration. The 13 pM cholesterol curve
is extrapolated (-----) to the expected asymptote.
boxyl group linked to the macrolide lactone ring and an amino group in the gly-
cosidic moiety. The N-acetylated derivative became, instead, fluorescent, in the
presence of membranes, only at acidic pH, confirming the requirement of the
absence of a net charge for formation of a fluorescent complex.
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FounRE 4 Decrease of fluorescence upon addition of lecithin to a lucensomycin-choles-
terol aqueous suspension. Cholesterol was 20 FM, added as a colloidal aqueous suspen-
sion. Lucensomycin was 1.5 IM. Fluorescence is expressed as conventional units. The
expeimental points correspond to lecithin:cholesterol ratios, on a weight basis, of 0, 0.4, 1,
and 2.4.
Lucensomycin Fluorescence in Model Systems
Addition of micelles prepared with the total lipid fraction from beef erythrocytes
to lucensomycin in aqueous solution at neutral pH gave a fluorescence increase,
with titration curves identical, on a cholesterol basis, with those obtained with
whole erythrocyte ghosts. If, to the polyene in aqueous solution, rat liver mito-
chondrial fragments or phospholipid (egg lecithin) micelles were added, a moderate
increase of fluorescence occurred. As previously reported (1), lucensomycin also
exhibited some fluorescence when dissolved in a number of organic solvents. No
direct relation between the intensity of emission and the polarity of the solvent,
expressed either as dielectric constant or as Z value (10), could be evidenced, the
fluorescence being stronger in dimethylsulfoxide or even in formamide than in
n-hexane. The quantum yield reached, at best (i.e., in dioxane), a value of 0.026,
which is only H of that obtained with membranes in water (1). With dioxane or
chloroform as solvents, addition of membranes or of cholesterol did not cause
any further increase of fluorescence; when, instead, cholesterol was included in
phospholipid micelles suspended in aqueous medium, fluorescence reached values
comparable with those obtained with erythrocyte membranes, the maximal fluo-
rescence reached apparently depending on the cholesterol: phospholipid ratio (Fig.
2).
Indeed, addition of a colloidal suspension of cholesterol in water was also able
to cause the increase of lucensomycin fluorescence in phospholipid-free aqueous
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FIGURE 5 Kinetics of the fluorescence increase upon addition, to lucensomycin in aqueous
medium, of cholesterol in colloidal suspension. Both scales are logarithmic. In A, lucenso-
mycin was 8.5 pM, and cholesterol 2 AM (5-*),S pM (A--A) or 20 AM (N-U).
In B, lcensomycin was 2 uM, and cholesterol 1 puM (0-0O), 2.5 uM (AA) or 10
pM ) - 0). Fluorescence is expressed in arbitrary units.
media. Typical titration curves can thus be obtained (Fig. 3 A). As a matter of fact,
addition of phospholipids decreased, sometimes to a considerable extent, the fluo-
rescence of lucensomycin-cholesterol complexes (Fig. 4). The reason for this be-
havior shall be discussed in the second paper of this series (11).
A considerable difference could be evidenced when the kinetics of fluorescence
increase due to the presence of phospholipid-free colloidal cholesterol or to erythro-
cyte membrane were compared. In the former case, a half-time between 40 min and
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FiouRE 6 Time-dependent variation of fluorometric titration curves, with 5.4 IAM lucenso-
mycin and increasing cholesterol. The various solutions were mixed at time 0, and the fluores-
cence intensity measured, on duplicate samples, after 25-30 min (- - -), 120-125
min ( ), and 960-965 min (----). (No further variations of shape of the titration curves
occurred with time up to 3 days.) Experimental points are omitted for sake of clarity.
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FiouRE 7 Fluorescence spectra of lucensomycin at liquid nitrogen (77°K) or at room
temperature (298°K), in the absence (---: L) or in the presence ( -: LM) of erythro-
cyte membranes. The spectra were recorded on the Aminco-Bowman spectrophotofluo-
rometer equipped for phosphorimetry, but without inserting the chopper. The sample,
containing 3 ,uM lucensomycin and, if the case, 28 ,uM membrane cholesterol in ethylene
glycol-water 1:1 (v/v), was put in a quartz tube (2 mmn, internal diameter) surrounded
by an optically transparent Dewar with (77°K) or without (298°K) liquid nitrogen.
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FIGuRE 8 Variations in absorption spectra of lucensomycin in aqueous medium upon
addition of colloidal cholesterol (B) or of sodium deoxycholate (A). Above (A): lucenso-
mycin 2 pM in the absence ( ) or presence (--)of 12 mM sodium deoxycholate.
Below (B): lucensomycin 5.4 juM in the absence or presence of 2.0 pM (---) or 5.5
;&M ( ---)colloidal cholesterol. In both cases, spectra were recorded at equi-
libriunm.
130 min was found in the range of our experimental conditions: in the latter one
(Fig. 5), as already mentioned, the reaction was complete within the first minute.
Such a behavior could lead to misevaluations of titration curves (Fig. 6). Lucenso-
mycin fluorescence in aqueous solution could also be enhanced by addition of
steroids such as cholate, deoxycholate, or digitonin. Quabain was, instead, ineffec-
tive. Fig. 3 B illustrates the titration curve of 6 mM deoxycholate with increasing
amounts of lucensomycin: the maximal fluorescence is sensibly'lower, on a steroid
basis, than that obtained with cholesterol or with erythrocyte ghosts.
T'he shapes of the excitation and emission spectra of lucensomycin-cholesterol
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and lucensomycin-membrane complexes are identical and do not depend on the
lucensomycin:steroid ratio. Except for a small difference in the relative height of
the 305 and 320 nm peaks, they are also close, apart from the intensity, to those
obtained with lucensomycin alone in dioxane or chloroform (see also reference 1).
At liquid nitrogen temperature (77°K), in an ethylene glycol-water (1:1, v/v)
glass, lucensomycin alone showed a well-measurable fluorescence, centered at
405 =F5 nm (Fig. 7). Addition of erythrocyte membranes did not lead to a sig-
nificant increase of fluorescence intensity. At room temperature, under otherwise
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FiouRE 9 Above (A): CD spectra of 30 pM lucensomycin in the absence (-) or pres-
ence (-) of 35.6 AM erythrocyte cholesterol. [01 is expressed as millidegrees.
Below (B): absorption spectra of 7 pM lucensomycin in the absence (-) or the pres-
ence of 3.1 IM (-) or 12.4 uM (- *-*) erythrocyte membrane cholesterol. In the
reference cuvettes, blanks without the polyene.
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FIGURE 10 Kinetics of the variations of the optical density at 320 nm upon addition of
cholesterol in colloidal suspensions to lucensomycin in aqueous medium. Both scales are
logarithmic. Symbols are the same as in Fig. 5: 0 0 lucensomycin 2 p&M + choles-
terol 10 ,M; A-A: lucensomycin 8.5 ,uM + cholesterol 5 ,uM; U-: lucensomy-
cin 8.5 pM + cholesterol 20 pM. Fluorescence as arbitrary units.
identical conditions, the intensity of lucensomycin alone was too low to be measured
and increased sensibly, though not as much as in the absence of ethylene glycol,
upon addition of membranes. Phosphorescence at 77°K was very weak, detectable
only if fluorescence had been suppressed by use of rotating windows, and it did not
vary upon addition of membranes.
The mobility of the fluorescent species at room temperature was investigated by
use of fluorescence polarization measurements. In 90-100% dioxane, lucensomycin
alone had p = 0.21 and did not vary upon addition of membranes. In aqueous
medium and in the presence of colloidal cholesterol we found p = 0.31-0.32,
without any variation due to increased cholesterol:lucensomycin ratio or to the
progress of the reaction. In erythrocyte membranes, either before or after sonication,
we found p = 0.40-0.42.
The binding of lucensomycin to free steroids or to erythrocyte membranes was
accompanied by changes in the absorption spectrum of the polyene. In the presence
of colloidal cholesterol, at equilibrium, there was a decrease of the whole absorption
spectrum; in the presence of cholate or deoxycholate there was, instead, mainly a
red shift, with little or no variation ofextinction coefficient (Fig. 8). Upon addition of
erythrocyte membranes, a small red shift was associated with a reduced intensity
of the absorption bands of the polyene, especially of that at 320 nm. This variation
was also detectable, with even greater ease due to noninterference, in this region of
the relatively small light scattering of the membranes, in CD spectra (Fig. 9).
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FiouRE 11 Spectrophotometric titration of 5.4 IM lucensomycin with increasing amounts
of cholesterol. The absorption at 320 unm of samples to which various amounts of colloidal
cholesterol had been added was measured 960 min after mixing. It should be noted that
this curve, belonging to the same experiment, corresponds to the final curve of the fluoro-
metric titration illustrated in Fig. 6.
Kinetically, the variations of lucensomycin absorption spectra upon addition of
membranes occurred within the first minute after mixing, while upon addition of
colloidal cholesterol the reaction required several minutes (Fig. 10). Some differ-
ences between the fluorescence and the absorption variations were, however, present
and are apparent from a careful comparison of Figs. 5 and 10: the curves at 8.5
,uM lucensomycin and 5 ,uM cholesterol (A A) and at 2 AM lucensomycin and
10 MuM cholesterol (0 O) are almost superimposable in Fig. 5, and differ to a
large extent in Fig. 10. Waiting for equilibrium to be reached, a titration of a known
amount of lucensomycin with varying cholesterol concentration can be performed,
as shown in Fig. 11.
DISCUSSION
The results presented in this paper confirm previous reports (12-14) indicating that
the main binding site of polyenic antibiotics to membranes is the cholesterol moiety.
When this work had almost been completed, two reports appeared: one (15) re-
porting modifications of the absorption spectrum of the related macrolide polyene
filipin upon addition of cholesterol or of membranes, the other (16) reporting similar
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modifications, as well as fluorescence increase, upon binding to cholesterol of a
third polyene, pimaricin.
The reason for the increased fluorescence of lucensomycin upon addition of
cholesterol or of erythrocyte membranes does not appear to be due to formation
of an exciplex, i.e., to arise from the excitation of the lucensomycin-cholesterol
complex. In fact, in such a case the emission spectrum of the cholesterol-bound
polyene should have been shifted to longer wavelengths as compared with that of
the free polyene in organic solvents, and this is not the case. It appears more likely
that the fluorescence of free lucensomycin is quenched, at room temperature, by
the aqueous solvent, through internal or collisional energy loss. Either when it is at
liquid nitrogen temperature or when it is bound to cholesterol, this quenching
effect decreases, and fluorescence appears. At 77°K addition of membranes does not
bring about any further increase of fluorescence; no thorough investigation of the
temperature dependence of the binding of lucensomycin to membranes was, how-
ever, performed. The absence of a net charge on the polyene molecule appears to be
a prerequisite for fluorescence.
It may be of interest that increase of fluorescence upon binding to cholesterol
has also been found by Schroeder et al. (16) with pimaricin, which is, like lucenso-
mycin, an amphoteric tetraene. Filipin, which has no ionizable groups, is fluo-
rescent per se; upon binding to cholesterol containing membranes its fluorescence
did not, in our hands, vary, although Schroeder et al. (16) have reported a decrease
and Lagwiaska et al. (18) an increase of fluorescence. The size of macrolide ring
can also be of importance: preliminary experiments with nystatin and amphotericin
B, amphoteric polyenes with very large rings, indicated that only a minor increase
of fluorescence intensity occurred.
Binding of the polyene to cholesterol or to membranes causes a conspicuous im-
mobilization of the molecule, the polarization factor increasing from 0.21 (in
dioxane) to 0.31 and to 0.41, respectively. This shows that the macrolide ring,
which is always relatively rigid, becomes almost fixed when included in a mem-
brane structure, it may be recalled that the maximum value forp is 0.50.
In the accompanying paper (11), it shall be shown that at high cholesterol, or
membrane, concentration, the titration curve with increasing amounts of lucenso-
mycin is a straight line starting from the origin and reaching the horizontal asymp-
tote. The abscissa of the intersection with the asymptote gives the number of polyene
molecules which combine, under optimal conditions, to each sterol molecule.
From the data of Fig. 3 the fluorescent complex appears to be of the type LC2.
A similar ratio is also obtained from the spectrophotometric titration of Fig. 11.
This result is at variance with those obtained with other polyenes by Norman et al.
(15) and by Schroeder et al. (16); reasons for this discrepancy are not known.
As for the equilibrium constant of the reaction, the discrepancies between fluoro-
metric (Fig. 6) and spectrophotometric (Fig. 11) titrations do not afford to evaluate
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it. In contrast to what shall be shown with erythrocyte membranes in the accom-
panying paper (11), with colloidal cholesterol both spectrophotometric and fluo-
rometric titration curves, though different, would allow us to assume that the two
binding sites are equivalent, both as an intrinsic equilibrium constant and as a
fluorescence quantum yield. From the fluorometric curves, the equilibrium constant
would be of the order of 0.1-0.3 ,sM; from the spectrophotometric ones, it would
be at least 10 times smaller.
Receivedfor publication 5 June 1972 and in revisedform 24 January 1973.
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